company background image
CLOV logo

Clover Health Investments Informe acción NasdaqGS:CLOV

Último precio

US$3.37

Capitalización de mercado

US$1.7b

7D

10.9%

1Y

224.0%

Actualizada

22 Nov, 2024

Datos

Finanzas de la empresa +

Clover Health Investments, Corp.

Informe acción NasdaqGS:CLOV

Capitalización de mercado: US$1.7b

Competidores de Clover Health Investments, Corp.

Historial de precios y rendimiento

Resumen de todos los máximos históricos, cambios y caídas de precios de Clover Health Investments
Precios históricos de las acciones
Precio actual de la acciónUS$3.37
Máximo en las últimas 52 semanasUS$4.71
Mínimo de 52 semanasUS$0.61
Beta2.04
1Cambio en 1 mes-10.85%
Variación en 3 meses0.90%
Cambio de 1 año224.04%
3Variación en 3 años-37.71%
Variación en 5 añosn/a
Variación desde la OPV-66.96%

Noticias y actualizaciones recientes

Clover Health: Buy The Dip, Reap The Rewards

Nov 18

Clover Health Investments, Corp. (NASDAQ:CLOV) Just Reported Third-Quarter Earnings And Analysts Are Lifting Their Estimates

Nov 08
Clover Health Investments, Corp. (NASDAQ:CLOV) Just Reported Third-Quarter Earnings And Analysts Are Lifting Their Estimates

Clover Health's Rally: The Payoff Of A Profitable Pivot

Nov 06

Recent updates

Clover Health: Buy The Dip, Reap The Rewards

Nov 18

Clover Health Investments, Corp. (NASDAQ:CLOV) Just Reported Third-Quarter Earnings And Analysts Are Lifting Their Estimates

Nov 08
Clover Health Investments, Corp. (NASDAQ:CLOV) Just Reported Third-Quarter Earnings And Analysts Are Lifting Their Estimates

Clover Health's Rally: The Payoff Of A Profitable Pivot

Nov 06

There's Reason For Concern Over Clover Health Investments, Corp.'s (NASDAQ:CLOV) Massive 37% Price Jump

Oct 03
There's Reason For Concern Over Clover Health Investments, Corp.'s (NASDAQ:CLOV) Massive 37% Price Jump

Clover Health: Changing Business Model, Seeking Profitability

Oct 03

Clover Health: A Profitable Future Ahead Fueled By AI And Star Rating Success

Aug 15

Clover Health Investments, Corp. (NASDAQ:CLOV) Surges 32% Yet Its Low P/S Is No Reason For Excitement

Aug 14
Clover Health Investments, Corp. (NASDAQ:CLOV) Surges 32% Yet Its Low P/S Is No Reason For Excitement

Here's Why We're Watching Clover Health Investments' (NASDAQ:CLOV) Cash Burn Situation

Aug 06
Here's Why We're Watching Clover Health Investments' (NASDAQ:CLOV) Cash Burn Situation

Clover Health Investments, Corp.'s (NASDAQ:CLOV) Price Is Right But Growth Is Lacking After Shares Rocket 26%

Jun 12
Clover Health Investments, Corp.'s (NASDAQ:CLOV) Price Is Right But Growth Is Lacking After Shares Rocket 26%

Clover Health Investments, Corp.'s (NASDAQ:CLOV) 26% Dip In Price Shows Sentiment Is Matching Revenues

Apr 20
Clover Health Investments, Corp.'s (NASDAQ:CLOV) 26% Dip In Price Shows Sentiment Is Matching Revenues

Clover Health Investments, Corp. (NASDAQ:CLOV) Analysts Are Reducing Their Forecasts For This Year

Mar 16
Clover Health Investments, Corp. (NASDAQ:CLOV) Analysts Are Reducing Their Forecasts For This Year

Will Clover Health Investments (NASDAQ:CLOV) Spend Its Cash Wisely?

Mar 06
Will Clover Health Investments (NASDAQ:CLOV) Spend Its Cash Wisely?

Clover Health: Its Luck May Have Ran Out

Feb 26

Here's Why We're Not Too Worried About Clover Health Investments' (NASDAQ:CLOV) Cash Burn Situation

Nov 21
Here's Why We're Not Too Worried About Clover Health Investments' (NASDAQ:CLOV) Cash Burn Situation

We're Hopeful That Clover Health Investments (NASDAQ:CLOV) Will Use Its Cash Wisely

Jul 07
We're Hopeful That Clover Health Investments (NASDAQ:CLOV) Will Use Its Cash Wisely

Chamath Palihapitiya-linked Clover Health Investments trading near all-time low

Oct 14

Chamath Palihapitiya cuts stake in Clover Health to under 5%

Oct 04

Rethinking My Clover Health Position

Sep 12

Clover Paid The Price Of Its Alleged Lies; Time To Move On

Aug 17

Clover Health Investments to name president Andrew Toy as CEO

Aug 08

Clover Health Is A Buy Ahead Of Earnings

Jul 29

Clover Health to expand Medicare Advantage plans to 13 additional counties, exit 2

Jul 15

Is Clover Health A Good Healthcare Sector Stock Pick?

Jun 30

Rentabilidad de los accionistas

CLOVUS HealthcareMercado US
7D10.9%1.0%0.3%
1Y224.0%2.9%31.1%

Rentabilidad vs. Industria: CLOV superó a la industria US Healthcare, que obtuvo un rendimiento del 2.9% el año pasado.

Rentabilidad vs. Mercado: CLOV superó al mercado US, que obtuvo un rendimiento del 31.1% el año pasado.

Volatilidad de los precios

Is CLOV's price volatile compared to industry and market?
CLOV volatility
CLOV Average Weekly Movement13.0%
Healthcare Industry Average Movement7.1%
Market Average Movement6.2%
10% most volatile stocks in US Market15.8%
10% least volatile stocks in US Market3.1%

Precio estable de las acciones: El precio de las acciones de CLOV ha sido volátil en los últimos 3 meses.

Volatilidad a lo largo del tiempo: La volatilidad semanal de CLOV(13%) se ha mantenido estable durante el último año, pero sigue siendo superior al 75% de las acciones de US.

Acerca de la empresa

FundadaEmpleadosCEOPágina web
n/a552Andrew Toywww.cloverhealth.com/en/

Clover Health Investments, Corp. ofrece planes medicare advantage en Estados Unidos. Opera a través de dos segmentos: Seguros y No seguros. También ofrece Clover Assistant, una plataforma de software basada en la nube, que permite a los médicos detectar, identificar y gestionar antes las enfermedades crónicas; y acceso a información basada en datos y personalizada para los pacientes que tratan.

Resumen de fundamentos de Clover Health Investments, Corp.

¿Cómo se comparan los beneficios e ingresos de Clover Health Investments con su capitalización de mercado?
Estadísticas fundamentales de CLOV
Capitalización bursátilUS$1.68b
Beneficios(TTM)-US$95.94m
Ingresos (TTM)US$2.12b

0.8x

Ratio precio-ventas (PS)

-17.6x

Ratio precio-beneficio (PE)

Beneficios e Ingresos

Estadísticas clave de rentabilidad del último informe de resultados (TTM)
Cuenta de resultados (TTM) de CLOV
IngresosUS$2.12b
Coste de los ingresosUS$1.78b
Beneficio brutoUS$330.39m
Otros gastosUS$426.33m
Beneficios-US$95.94m

Últimos beneficios comunicados

Sep 30, 2024

Próxima fecha de beneficios

n/a

Beneficios por acción (BPA)-0.19
Margen bruto15.62%
Margen de beneficio neto-4.54%
Ratio deuda/patrimonio0%

¿Cómo se ha desempeñado CLOV a largo plazo?

Ver rendimiento histórico y comparativa